Cooper University Hospital Hematology and Medical Oncology

Topics

• Prostate Cancer Treatment and Research 21
• Multiple Myeloma Research and Treatments 20
• Lymphoma Diagnosis and Treatment 17
• Palliative Care and End-of-Life Issues 15
• BRCA gene mutations in cancer 14
• Cancer Immunotherapy and Biomarkers 13
• Acute Myeloid Leukemia Research 12
• CAR-T cell therapy research 10
• Hematopoietic Stem Cell Transplantation 10
• Neuroendocrine Tumor Research Advances 9
• Advanced Breast Cancer Therapies 8
• Cancer survivorship and care 8

Most cited

1. Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 381 citations · Ravi Gupta

2. Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers.

   ESMO open · 2022 · 289 citations · Ryan Stephenson, Kristen Spencer

3. North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need.

   Blood · 2023 · 58 citations · Tulin Budak-Alpdogan

4. Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1.

   Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2023 · 78 citations · Ravi Gupta

5. Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 65 citations ·